280 related articles for article (PubMed ID: 12922928)
21. Antitussive activity of iodo-resiniferatoxin in guinea pigs.
Trevisani M; Milan A; Gatti R; Zanasi A; Harrison S; Fontana G; Morice AH; Geppetti P
Thorax; 2004 Sep; 59(9):769-72. PubMed ID: 15333853
[TBL] [Abstract][Full Text] [Related]
22. Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential.
Appendino G; De Petrocellis L; Trevisani M; Minassi A; Daddario N; Moriello AS; Gazzieri D; Ligresti A; Campi B; Fontana G; Pinna C; Geppetti P; Di Marzo V
J Pharmacol Exp Ther; 2005 Feb; 312(2):561-70. PubMed ID: 15356216
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat.
Jakab B; Helyes Z; Varga A; Bölcskei K; Szabó A; Sándor K; Elekes K; Börzsei R; Keszthelyi D; Pintér E; Petho G; Németh J; Szolcsányi J
Eur J Pharmacol; 2005 Jul; 517(1-2):35-44. PubMed ID: 15978575
[TBL] [Abstract][Full Text] [Related]
24. Differential pH and capsaicin responses of Griffonia simplicifolia IB4 (IB4)-positive and IB4-negative small sensory neurons.
Liu M; Willmott NJ; Michael GJ; Priestley JV
Neuroscience; 2004; 127(3):659-72. PubMed ID: 15283965
[TBL] [Abstract][Full Text] [Related]
25. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.
Walker KM; Urban L; Medhurst SJ; Patel S; Panesar M; Fox AJ; McIntyre P
J Pharmacol Exp Ther; 2003 Jan; 304(1):56-62. PubMed ID: 12490575
[TBL] [Abstract][Full Text] [Related]
26. Cloning and functional characterization of dog transient receptor potential vanilloid receptor-1 (TRPV1).
Phelps PT; Anthes JC; Correll CC
Eur J Pharmacol; 2005 Apr; 513(1-2):57-66. PubMed ID: 15878709
[TBL] [Abstract][Full Text] [Related]
27. Transient receptor potential vanilloid-1-mediated calcium responses are inhibited by the alkylamine antihistamines dexbrompheniramine and chlorpheniramine.
Sadofsky LR; Campi B; Trevisani M; Compton SJ; Morice AH
Exp Lung Res; 2008 Dec; 34(10):681-93. PubMed ID: 19085565
[TBL] [Abstract][Full Text] [Related]
28. Resiniferatoxin-type phorboid vanilloids display capsaicin-like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VR1.
Szallasi A; Szabó T; Bíró T; Modarres S; Blumberg PM; Krause JE; Cortright DN; Appendino G
Br J Pharmacol; 1999 Sep; 128(2):428-34. PubMed ID: 10510454
[TBL] [Abstract][Full Text] [Related]
29. Binding of [(3)H]A-778317 to native transient receptor potential vanilloid-1 (TRPV1) channels in rat dorsal root ganglia and spinal cord.
Bianchi BR; El Kouhen R; Chen J; Puttfarcken PS
Eur J Pharmacol; 2010 May; 633(1-3):15-23. PubMed ID: 20153316
[TBL] [Abstract][Full Text] [Related]
30. Functional study on TRPV1-mediated signalling in the mouse small intestine: involvement of tachykinin receptors.
de Man JG; Boeckx S; Anguille S; de Winter BY; de Schepper HU; Herman AG; Pelckmans PA
Neurogastroenterol Motil; 2008 May; 20(5):546-56. PubMed ID: 18194153
[TBL] [Abstract][Full Text] [Related]
31. Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin.
Kanai Y; Hara T; Imai A
J Pharm Pharmacol; 2006 Apr; 58(4):489-93. PubMed ID: 16597366
[TBL] [Abstract][Full Text] [Related]
32. TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats.
De Schepper HU; De Man JG; Ruyssers NE; Deiteren A; Van Nassauw L; Timmermans JP; Martinet W; Herman AG; Pelckmans PA; De Winter BY
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G245-53. PubMed ID: 17991707
[TBL] [Abstract][Full Text] [Related]
33. Fatty acyl amides of endogenous tetrahydroisoquinolines are active at the recombinant human TRPV1 receptor.
O'Dell DK; Rimmerman N; Pickens SR; Walker JM
Bioorg Med Chem; 2007 Sep; 15(18):6164-9. PubMed ID: 17616464
[TBL] [Abstract][Full Text] [Related]
34. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
35. Design of a high-affinity competitive antagonist of the vanilloid receptor selective for the calcium entry-linked receptor population.
Tóth A; Blumberg PM; Chen Z; Kozikowski AP
Mol Pharmacol; 2004 Feb; 65(2):282-91. PubMed ID: 14742669
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
[TBL] [Abstract][Full Text] [Related]
37. Capsazepine, a vanilloid antagonist, abolishes tonic responses induced by 20-HETE on guinea pig airway smooth muscle.
Rousseau E; Cloutier M; Morin C; Proteau S
Am J Physiol Lung Cell Mol Physiol; 2005 Mar; 288(3):L460-70. PubMed ID: 15557084
[TBL] [Abstract][Full Text] [Related]
38. Identification of species-specific determinants of the action of the antagonist capsazepine and the agonist PPAHV on TRPV1.
Phillips E; Reeve A; Bevan S; McIntyre P
J Biol Chem; 2004 Apr; 279(17):17165-72. PubMed ID: 14960593
[TBL] [Abstract][Full Text] [Related]
39. Block of native and cloned vanilloid receptor 1 (TRPV1) by aminoglycoside antibiotics.
Raisinghani M; Premkumar LS
Pain; 2005 Jan; 113(1-2):123-33. PubMed ID: 15621372
[TBL] [Abstract][Full Text] [Related]
40. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat.
Varga A; Németh J; Szabó A; McDougall JJ; Zhang C; Elekes K; Pintér E; Szolcsányi J; Helyes Z
Neurosci Lett; 2005 Sep; 385(2):137-42. PubMed ID: 15950380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
